Charles Schwab Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Buy |
4,735
+69
| +1% | +$3.19K | 0.02% | 170 |
|
|
2025
Q1 | $285K | Buy |
+4,666
| New | +$285K | 0.02% | 150 |
|
|
2024
Q1 | – | Sell |
-5,021
| Closed | -$258K | – | 158 |
|
|
2023
Q4 | $258K | Buy |
5,021
+35
| +0.7% | +$1.8K | 0.03% | 150 |
|
|
2023
Q3 | $289K | Sell |
4,986
-67
| -1% | -$3.89K | 0.03% | 143 |
|
|
2023
Q2 | $326K | Sell |
5,053
-2,433
| -33% | -$157K | 0.04% | 115 |
|
|
2023
Q1 | $519K | Sell |
7,486
-3,363
| -31% | -$233K | 0.06% | 97 |
|
|
2022
Q4 | $781K | Hold |
10,849
| – | – | 0.1% | 85 |
|
|
2022
Q3 | $771K | Hold |
10,849
| – | – | 0.13% | 83 |
|
|
2022
Q2 | $835K | Buy |
10,849
+147
| +1% | +$11.3K | 0.17% | 77 |
|
|
2022
Q1 | $782K | Sell |
10,702
-3,080
| -22% | -$225K | 0.14% | 84 |
|
|
2021
Q4 | $859K | Sell |
13,782
-303
| -2% | -$18.9K | 0.14% | 87 |
|
|
2021
Q3 | $833K | Buy |
14,085
+303
| +2% | +$17.9K | 0.16% | 95 |
|
|
2021
Q2 | $921K | Sell |
13,782
-64
| -0.5% | -$4.28K | 0.18% | 87 |
|
|
2021
Q1 | $871K | Sell |
13,846
-8,089
| -37% | -$509K | 0.18% | 89 |
|
|
2020
Q4 | $1.36M | Buy |
21,935
+8,205
| +60% | +$509K | 0.33% | 68 |
|
|
2020
Q3 | $828K | Sell |
13,730
-639
| -4% | -$38.5K | 0.25% | 75 |
|
|
2020
Q2 | $843K | Buy |
14,369
+829
| +6% | +$48.6K | 0.28% | 71 |
|
|
2020
Q1 | $755K | Sell |
13,540
-175
| -1% | -$9.76K | 0.31% | 71 |
|
|
2019
Q4 | $880K | Buy |
13,715
+5,107
| +59% | +$328K | 0.34% | 70 |
|
|
2019
Q3 | $436K | Buy |
+8,608
| New | +$436K | 0.2% | 88 |
|